SANOFI VENTURES
Sanofi Ventures is the corporate venture capital arm of Sanofi. We have the ability to seed and to lead financings in early-stage companies with innovative ideas and transformative new products and technologies that are of strategic interest to Sanofi. Among these areas are rare diseases, oncology, immunology and inflammation, vaccines, potential cures in other core areas of Sanofi’s business footprint, and digital health and data science solutions.
SANOFI VENTURES
Industry:
Biotechnology Financial Services Health Care
Founded:
1994-01-01
Status:
Active
Technology used in webpage:
Amazon
Similar Organizations
Saint-Gobain NOVA
Saint-Gobain NOVA is the ventures arm of Saint‑Gobain.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-29 | ReCode Therapeutics | Sanofi Ventures investment in Series B - ReCode Therapeutics | 120 M USD |
| 2022-04-27 | OMass Technologies | Sanofi Ventures investment in Series B - OMass Technologies | 75.5 M GBP |
| 2022-03-22 | Nucleai | Sanofi Ventures investment in Series B - Nucleai | 33 M USD |
| 2021-10-22 | Click Therapeutics | Sanofi Ventures investment in Series B - Click Therapeutics | 52 M USD |
| 2021-10-21 | ReCode Therapeutics | Sanofi Ventures investment in Series B - ReCode Therapeutics | 80 M USD |
| 2021-09-29 | Expansion Therapeutics | Sanofi Ventures investment in Series B - Expansion Therapeutics | 80 M USD |
| 2021-09-14 | ROME Therapeutics | Sanofi Ventures investment in Series B - ROME Therapeutics | 77 M USD |
| 2021-07-09 | Muna Therapeutics | Sanofi Ventures investment in Series A - Muna Therapeutics | 73 M USD |
| 2021-06-23 | Glycomine | Sanofi Ventures investment in Series B - Glycomine | 35 M USD |
| 2021-06-16 | Veralox Therapeutics | Sanofi Ventures investment in Series A - Veralox Therapeutics | 16.6 M USD |